ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $572,588 | +2.0% | 8,455 | +7.8% | 0.12% | +9.5% |
Q2 2023 | $561,153 | +6.8% | 7,841 | +3.6% | 0.10% | -1.9% |
Q1 2023 | $525,268 | +17.1% | 7,567 | +14.3% | 0.11% | +10.3% |
Q4 2022 | $448,726 | +45.2% | 6,618 | +17.6% | 0.10% | +31.1% |
Q3 2022 | $309,000 | -16.5% | 5,626 | +0.5% | 0.07% | -19.6% |
Q2 2022 | $370,000 | +10.1% | 5,600 | +10.5% | 0.09% | +21.1% |
Q1 2022 | $336,000 | +38.3% | 5,069 | +21.4% | 0.08% | +35.7% |
Q4 2021 | $243,000 | -19.5% | 4,175 | -17.1% | 0.06% | -24.3% |
Q3 2021 | $302,000 | +33.0% | 5,036 | +32.7% | 0.07% | +29.8% |
Q2 2021 | $227,000 | +176.8% | 3,796 | +86.9% | 0.06% | +103.6% |
Q1 2019 | $82,000 | +6.5% | 2,031 | 0.0% | 0.03% | -6.7% |
Q4 2018 | $77,000 | +35.1% | 2,031 | +38.6% | 0.03% | +42.9% |
Q3 2018 | $57,000 | +5.6% | 1,465 | 0.0% | 0.02% | +5.0% |
Q2 2018 | $54,000 | +28.6% | 1,465 | +27.8% | 0.02% | +17.6% |
Q1 2018 | $42,000 | +7.7% | 1,146 | 0.0% | 0.02% | +6.2% |
Q4 2017 | $39,000 | – | 1,146 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |